Last news
Mariah Carey's 'Here For It All' Becomes Her Most-Streamed Studio Album Launch in China

Mariah Carey's 'Here For It All' Becomes Her Most-Streamed Studio Album Launch in China

HANGZHOU, China, Nov. 7, 2025 /PRNewswire/ -- Mariah Carey's Here For It All made headlines in the U.S. with a No. 7 debut on the Billboard 200. It also landed No. 1 placements across Top Album Sales, Top R&B Albums, and Independent Albums. But...

Mantle Collaborates with Bybit and Backed to Bring U.S. Equities Onchain, Pioneering Next Trillion-Dollar Wave of Tokenized Assets

Mantle Collaborates with Bybit and Backed to Bring U.S. Equities Onchain, Pioneering Next Trillion-Dollar Wave of Tokenized Assets

DUBAI, UAE, Nov. 7, 2025 /PRNewswire/ -- Mantle, the high-performance distribution and liquidity layer for real-world assets (RWAs), together with Bybit and Backed, today announced its strategic collaboration to bring tokenized U.S. equities onchain...

Symbiotic Cosmos: A Dialogue on Reconstructing Design Education Ecosystem Amidst Technological Iteration

Symbiotic Cosmos: A Dialogue on Reconstructing Design Education Ecosystem Amidst Technological Iteration

HANGZHOU, China, Nov. 7, 2025 /PRNewswire/ -- The China (Hangzhou) Art and Technology Biennale opened at Yuhang Art Museum, Hangzhou on October 18. It is initiated by the China Academy of Art (CAA) and curated by the CAA School of Design &...

HiBy RS8 II Ultra-Flagship Portable HiFi Player Released

HiBy RS8 II Ultra-Flagship Portable HiFi Player Released

LEWES, Del., Nov. 7, 2025 /PRNewswire/ -- HiBy has officially launched its new flagship portable HiFi player, RS8 II, on October 30, 2025. The RS8 II integrates HiBy's advanced technologies in portable audio with deep insights into market trends,...

Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025

Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025

Studies reveal how the Lunit SCOPE ® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ -- Lunit (KRX:328130), a leading...

Bitget Slashes Stock Futures Trading Fees by 90% as Daily Volume Surpasses $300 Million

Bitget Slashes Stock Futures Trading Fees by 90% as Daily Volume Surpasses $300 Million

VICTORIA, Seychelles, Nov. 7, 2025 /PRNewswire/ -- Bitget, the world's largest Universal Exchange (UEX), today announced a limited-time 90% reduction in stock futures trading fees, marking one of the most aggressive pricing initiatives ever launched...

Anchoring the 15th Five-Year Plan: China's High-quality Development is Strengthening Foreign Investors' Confidence

Anchoring the 15th Five-Year Plan: China's High-quality Development is Strengthening Foreign Investors' Confidence

BEIJING, Nov. 7, 2025 /PRNewswire/ -- A news report from China.org.cn on the 8th CIIE and China's high-quality development: Anchoring the 15th Five-Year Plan: China’s High-quality Development is Strengthening Foreign Investors’ Confidence Recently,...

HanchorBio Presents Two Late-Breaking Abstracts at the Society for Immunotherapy of Cancer 2025 Demonstrating Best-in-Class Potential of HCB101 in Advanced Cancers

HanchorBio Presents Two Late-Breaking Abstracts at the Society for Immunotherapy of Cancer 2025 Demonstrating Best-in-Class Potential of HCB101 in Advanced Cancers

Late-breaking poster presentations show HCB101's favorable safety, strong receptor occupancy, and promising monotherapy and combination activity in tumors historically unresponsive to immunotherapy TAIPEI, SHANGHAI, and SAN FRANCISCO, Nov. 7, 2025...

menu
menu